PCSK9 and atherosclerosis: In this framework, although no causality can be inferred by our findings, it becomes interesting to hypothesize an effect of PCSK9 on the release of EVs which are vehicles of bioactive molecules that influence various processes in atherosclerosis, namely, initiation, lesion progression, and hemostasis regulation (4).